Hepatitis B screening: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) No edit summary |
Joao Silva (talk | contribs) No edit summary |
||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
High risk groups, such as : persons born in high or intermediate [[endemic]] areas; United States– born persons not [[vaccinated]] as infants whose parents were born in regions with high [[HBV]] endemicity; persons needing [[immunosuppressive therapy]]; patients with history of [[IV]] drugs history; among others should be tested for [[HBV infection]]. | High risk groups, such as : persons born in high or intermediate [[endemic]] areas; United States– born persons not [[vaccinated]] as infants whose parents were born in regions with high [[HBV]] endemicity; persons needing [[immunosuppressive therapy]]; patients with history of [[IV]] drugs history; among others should be tested for [[HBV infection]]. | ||
==Screening== | ==Screening== | ||
===Recommendations for Persons Who Should Be Tested for HBV Infection: AASLD Practice Guidelines 2009<ref name="pmid15229781">{{cite journal |author=Lok AS, McMahon BJ |title=[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines] |journal=[[Romanian Journal of Gastroenterology]] |volume=13 |issue=2 |pages=150–4 |year=2004 |month=June |pmid=15229781 |doi= |url=http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/chronic_hep_b_update_2009%208_24_2009.pdf |accessdate=2012-02-10}}</ref>=== | ===Recommendations for Persons Who Should Be Tested for HBV Infection: AASLD Practice Guidelines 2009<ref name="pmid15229781">{{cite journal |author=Lok AS, McMahon BJ |title=[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines] |journal=[[Romanian Journal of Gastroenterology]] |volume=13 |issue=2 |pages=150–4 |year=2004 |month=June |pmid=15229781 |doi= |url=http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/chronic_hep_b_update_2009%208_24_2009.pdf |accessdate=2012-02-10}}</ref>=== | ||
Line 21: | Line 23: | ||
===Recommendations for HCC Screening: AASLD Practice Guidelines 2009<ref name="pmid15229781">{{cite journal |author=Lok AS, McMahon BJ |title=[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines] |journal=[[Romanian Journal of Gastroenterology]] |volume=13 |issue=2 |pages=150–4 |year=2004 |month=June |pmid=15229781 |doi= |url=http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/chronic_hep_b_update_2009%208_24_2009.pdf |accessdate=2012-02-10}}</ref>=== | ===Recommendations for HCC Screening: AASLD Practice Guidelines 2009<ref name="pmid15229781">{{cite journal |author=Lok AS, McMahon BJ |title=[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines] |journal=[[Romanian Journal of Gastroenterology]] |volume=13 |issue=2 |pages=150–4 |year=2004 |month=June |pmid=15229781 |doi= |url=http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/chronic_hep_b_update_2009%208_24_2009.pdf |accessdate=2012-02-10}}</ref>=== | ||
{{cquote| | {{cquote| | ||
* [[HBV]] carriers at high risk for [[HCC]] such as Asian men over 40 years and Asian women over 50 years of age | * [[HBV]] carriers at high risk for [[HCC]] such as Asian men over 40 years and Asian women over 50 years of age | ||
IU/mL should be screened with US examination every 6-12 months. (Grade II-2) | * Persons with [[cirrhosis]] | ||
* Persons with a family history of [[HCC]] | |||
* Africans over 20 years of age | |||
* Any carrier over 40 years with persistent or intermittent [[ALT]] elevation and/or high [[HBV]] [[DNA]] level >2,000 IU/mL should be screened with US examination every 6-12 months. (Grade II-2) | |||
* For [[HBV]] carriers]] at high risk for [[HCC]] who are living in areas where US is not readily available, periodic screening with AFP should be considered. (Grade II-2)}} | * For [[HBV]] carriers]] at high risk for [[HCC]] who are living in areas where US is not readily available, periodic screening with AFP should be considered. (Grade II-2)}} |
Revision as of 20:27, 29 July 2014
Hepatitis B |
Diagnosis |
Treatment |
Case Studies |
Hepatitis B screening On the Web |
American Roentgen Ray Society Images of Hepatitis B screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
High risk groups, such as : persons born in high or intermediate endemic areas; United States– born persons not vaccinated as infants whose parents were born in regions with high HBV endemicity; persons needing immunosuppressive therapy; patients with history of IV drugs history; among others should be tested for HBV infection.
Screening
Recommendations for Persons Who Should Be Tested for HBV Infection: AASLD Practice Guidelines 2009[1]
“ | The following groups should be tested for HBV infection:
|
” |
Recommendations for HCC Screening: AASLD Practice Guidelines 2009[1]
“ |
|
” |
References
- ↑ 1.0 1.1 Lok AS, McMahon BJ (2004). "[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]" (PDF). Romanian Journal of Gastroenterology. 13 (2): 150–4. PMID 15229781. Retrieved 2012-02-10. Unknown parameter
|month=
ignored (help)